MedPharm

On:

Denver-based Schwazze said it has terminated its planned acquisition of MedPharm, a medical marijuana company in the same city that landed Colorado’s first cannabis research and development license. Schwazze said earlier this year it had moved forward on numerous term sheets with Colorado cannabis operators but had completed limited dueContinue Reading

On:

Iowa medical cannabis regulators are opening up a license for a second cultivator/processor to replace multistate operator Acreage Holdings, which dropped out of the market earlier this year. The license could be critical for the 2-year-old program, which is struggling to be economically viable, partly because of high product prices.Continue Reading

On:

Iowa’s 2-year-old medical marijuana program is struggling to become financially viable, constrained by low THC levels, high prices, minimal physician participation – and more. While most marijuana markets across the country have experienced robust demand during the coronavirus pandemic, Iowa’s MMJ sales have been weak. Patients have struggled to renewContinue Reading

On:

The city of Denver issued its first medical marijuana research and development license to study MJ-related treatments for diseases. The license went to Denver-based medical marijuana company MedPharm. The permit allows the company to cultivate, process, manufacture and transfer marijuana to other laboratories or cannabis businesses for research purposes. AlbertContinue Reading

On:

Marijuana multistate operator Acreage Holdings relinquished its medical cannabis manufacturing license in Iowa, two months after halting operations at the facility. Acreage pulls out of Iowa medical marijuana market is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs Read More: Acreage pullsContinue Reading